Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.

Standard

Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. / Meyer, Sven; Adam, Matti; Schweiger, Brunhilde; Ilchmann, Corina; Zu Eulenburg, Christine Gräfin; Sattinger, Edgar; Runte, Hendrik; Schlüter, Michael; Deuse, Tobias; Reichenspurner, Hermann; Costardt-Jäckle, Angelika.

In: TRANSPLANTATION, Vol. 91, No. 9, 9, 2011, p. 1031-1035.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Meyer, S, Adam, M, Schweiger, B, Ilchmann, C, Zu Eulenburg, CG, Sattinger, E, Runte, H, Schlüter, M, Deuse, T, Reichenspurner, H & Costardt-Jäckle, A 2011, 'Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.', TRANSPLANTATION, vol. 91, no. 9, 9, pp. 1031-1035. <http://www.ncbi.nlm.nih.gov/pubmed/21358365?dopt=Citation>

APA

Meyer, S., Adam, M., Schweiger, B., Ilchmann, C., Zu Eulenburg, C. G., Sattinger, E., Runte, H., Schlüter, M., Deuse, T., Reichenspurner, H., & Costardt-Jäckle, A. (2011). Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. TRANSPLANTATION, 91(9), 1031-1035. [9]. http://www.ncbi.nlm.nih.gov/pubmed/21358365?dopt=Citation

Vancouver

Meyer S, Adam M, Schweiger B, Ilchmann C, Zu Eulenburg CG, Sattinger E et al. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. TRANSPLANTATION. 2011;91(9):1031-1035. 9.

Bibtex

@article{36ad76cce18d4311a1abeda24bb42303,
title = "Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.",
abstract = "Influenza A (H1N1) has emerged as a considerable threat for recipients of organ transplants. Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Enzyme-Linked Immunosorbent Assay, Immunoglobulin G/blood, Adjuvants, Immunologic/*administration & dosage, Antibodies, Viral/*blood, Heart Transplantation/*immunology, Hemagglutination Inhibition Tests, Influenza A Virus, H1N1 Subtype/*immunology, Influenza Vaccines/*administration & dosage/adverse effects, Influenza, Human/epidemiology/immunology/prevention & control, Pandemics/prevention & control, Adult, Humans, Male, Aged, Female, Middle Aged, Enzyme-Linked Immunosorbent Assay, Immunoglobulin G/blood, Adjuvants, Immunologic/*administration & dosage, Antibodies, Viral/*blood, Heart Transplantation/*immunology, Hemagglutination Inhibition Tests, Influenza A Virus, H1N1 Subtype/*immunology, Influenza Vaccines/*administration & dosage/adverse effects, Influenza, Human/epidemiology/immunology/prevention & control, Pandemics/prevention & control",
author = "Sven Meyer and Matti Adam and Brunhilde Schweiger and Corina Ilchmann and {Zu Eulenburg}, {Christine Gr{\"a}fin} and Edgar Sattinger and Hendrik Runte and Michael Schl{\"u}ter and Tobias Deuse and Hermann Reichenspurner and Angelika Costardt-J{\"a}ckle",
year = "2011",
language = "English",
volume = "91",
pages = "1031--1035",
journal = "TRANSPLANTATION",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

RIS

TY - JOUR

T1 - Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.

AU - Meyer, Sven

AU - Adam, Matti

AU - Schweiger, Brunhilde

AU - Ilchmann, Corina

AU - Zu Eulenburg, Christine Gräfin

AU - Sattinger, Edgar

AU - Runte, Hendrik

AU - Schlüter, Michael

AU - Deuse, Tobias

AU - Reichenspurner, Hermann

AU - Costardt-Jäckle, Angelika

PY - 2011

Y1 - 2011

N2 - Influenza A (H1N1) has emerged as a considerable threat for recipients of organ transplants. Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients.

AB - Influenza A (H1N1) has emerged as a considerable threat for recipients of organ transplants. Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Enzyme-Linked Immunosorbent Assay

KW - Immunoglobulin G/blood

KW - Adjuvants, Immunologic/administration & dosage

KW - Antibodies, Viral/blood

KW - Heart Transplantation/immunology

KW - Hemagglutination Inhibition Tests

KW - Influenza A Virus, H1N1 Subtype/immunology

KW - Influenza Vaccines/administration & dosage/adverse effects

KW - Influenza, Human/epidemiology/immunology/prevention & control

KW - Pandemics/prevention & control

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Enzyme-Linked Immunosorbent Assay

KW - Immunoglobulin G/blood

KW - Adjuvants, Immunologic/administration & dosage

KW - Antibodies, Viral/blood

KW - Heart Transplantation/immunology

KW - Hemagglutination Inhibition Tests

KW - Influenza A Virus, H1N1 Subtype/immunology

KW - Influenza Vaccines/administration & dosage/adverse effects

KW - Influenza, Human/epidemiology/immunology/prevention & control

KW - Pandemics/prevention & control

M3 - SCORING: Journal article

VL - 91

SP - 1031

EP - 1035

JO - TRANSPLANTATION

JF - TRANSPLANTATION

SN - 0041-1337

IS - 9

M1 - 9

ER -